1 Product identity
Ingredient risk
Contains restricted ingredients

Children's MigreLief

BrandAkeso→Botanical with Nutrients Capsule 14 ingredients 1 banned 1 caution DSLD #183011
Net contents: 60 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-11-21
2 Ingredients (14)
IngredientGroupSafety
RiboflavinRiboflavinGenerally Safe
MagnesiumMagnesiumUse with Caution
Puracol FeverfewFeverfew—
powdered CelluloseCellulose—
DextratesDextrates—
Stearic AcidStearic Acid—
Vegetable Gumvegetable gum (unspecified)—
Sodium Starch GlycolateSodium Starch Glycolate—
Silicon DioxideSiliconGenerally Safe
Hydroxypropyl MethylcelluloseHypromellose—
Titanium DioxideTitanium DioxideBanned in ≥1 country
Polyethylene GlycolPolyethylene glycol—
CarmineColor—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide  🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Riboflavin — Generally Safe
⚠ Harmless yellow urine
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Grape Seed Extract — Limited Evidence
⚠ Antiplatelet effect
⚠ May interact with anticoagulants
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID183011
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-11-21
6 More from Akeso
View Akeso Safety Scorecard → 3 products
MigreLief Triple Therapy with PuracolMigreLief-NOW
7 Cite this page
Vancouver
Pkhakadze G. Children's MigreLief — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/dsld-183011/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network